PMID- 20947696 OWN - NLM STAT- MEDLINE DCOM- 20101221 LR - 20190722 IS - 1530-8561 (Electronic) IS - 0009-9147 (Linking) VI - 56 IP - 12 DP - 2010 Dec TI - Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression. PG - 1845-53 LID - 10.1373/clinchem.2010.151233 [doi] AB - BACKGROUND: There is an increasing need for the identification of both DNA and RNA biomarkers from pathodiagnostic formalin-fixed paraffin-embedded (FFPE) tissue samples for the exploration of individualized therapy strategies in cancer. We investigated a fully automated, xylene-free nucleic acid extraction method for the simultaneous analysis of RNA and DNA biomarkers related to breast cancer. METHODS: We copurified both RNA and DNA from a single 10-mum section of 210 paired samples of FFPE tumor and adjacent normal tissues (1-25 years of archival time) using a fully automated extraction method. Half of the eluate was DNase I digested for mRNA expression analysis performed by using reverse-transcription quantitative PCR for the genes estrogen receptor 1 (ESR1), progesterone receptor (PGR), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), epoxide hydrolase 1 (EPHX1), baculoviral IAP repeat-containing 5 (BIRC5), matrix metallopeptidase 7 (MMP7), vascular endothelial growth factor A (VEGFA), and topoisomerase (DNA) II alpha 170kDa (TOP2A). The remaining undigested aliquot was used for the analysis of 7 single-nucleotide polymorphisms (SNPs) by MALDI-TOF mass spectrometry. RESULTS: In 208 of 210 samples (99.0%) the protocol yielded robust quantification-cycle values for both RNA and DNA normalization. Expression of the 8 breast cancer genes was detected in 81%-100% of tumor tissues and 21%-100% of normal tissues. The 7 SNPs were successfully genotyped in 91%-97% of tumor and 94%-97% of normal tissues. Allele concordance between tumor and normal tissue was 98.9%-99.5%. CONCLUSIONS: This fully automated process allowed an efficient simultaneous extraction of both RNA and DNA from a single FFPE section and subsequent dual analysis of selected genes. High gene expression and genotyping detection rates demonstrate the feasibility of molecular profiling from limited archival patient samples. FAU - Hennig, Guido AU - Hennig G AD - Siemens Healthcare Diagnostics Products, Molecular Research Germany, Cologne, Germany. FAU - Gehrmann, Mathias AU - Gehrmann M FAU - Stropp, Udo AU - Stropp U FAU - Brauch, Hiltrud AU - Brauch H FAU - Fritz, Peter AU - Fritz P FAU - Eichelbaum, Michel AU - Eichelbaum M FAU - Schwab, Matthias AU - Schwab M FAU - Schroth, Werner AU - Schroth W LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101014 PL - England TA - Clin Chem JT - Clinical chemistry JID - 9421549 RN - 0 (Biomarkers, Tumor) RN - 0 (Fixatives) RN - 0 (RNA, Messenger) RN - 1HG84L3525 (Formaldehyde) RN - 63231-63-0 (RNA) RN - 9007-49-2 (DNA) SB - IM MH - Automation, Laboratory MH - Biomarkers, Tumor/analysis MH - Breast Neoplasms/diagnosis/genetics/pathology MH - Cell Line, Tumor MH - DNA/*isolation & purification MH - Female MH - Fixatives MH - Formaldehyde MH - Gene Expression Profiling MH - Genotype MH - Humans MH - Paraffin Embedding MH - Polymerase Chain Reaction MH - *Polymorphism, Single Nucleotide MH - RNA/*isolation & purification MH - RNA, Messenger/*biosynthesis MH - Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization MH - Tissue Fixation EDAT- 2010/10/16 06:00 MHDA- 2010/12/22 06:00 CRDT- 2010/10/16 06:00 PHST- 2010/10/16 06:00 [entrez] PHST- 2010/10/16 06:00 [pubmed] PHST- 2010/12/22 06:00 [medline] AID - clinchem.2010.151233 [pii] AID - 10.1373/clinchem.2010.151233 [doi] PST - ppublish SO - Clin Chem. 2010 Dec;56(12):1845-53. doi: 10.1373/clinchem.2010.151233. Epub 2010 Oct 14.